Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment
Emerging Infectious Diseases · 2025-03 · 31 (3)
DOI: 10.3201/eid3103.241473 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2025-03. Verfasst von Valentina Gerussi und 14 weiteren Autor:innen. Hauptthemen laut MEDLINE: Isoniazid, Tuberculosis, Multidrug-Resistant, Antitubercular Agents, Mycobacterium tuberculosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Gerussi, V., Petersen, T., Bonnet, I., Aubry, A., Bachir, M., Gyde, E., Morel, F., Poignon, C., Rached, B., Pourcher, V., Rioux, C., Vallois, D., Veziris, N., Robert, J., & Guglielmetti, L. (2025). Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment. Emerging Infectious Diseases, 31(3). https://doi.org/10.3201/eid3103.241473
Vancouver
Gerussi V, Petersen T, Bonnet I, Aubry A, Bachir M, Gyde E, et al. Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment. Emerging Infectious Diseases. 2025;31(3). doi:10.3201/eid3103.241473
BibTeX
@article{Gerussi2025,
author = {Gerussi, Valentina and Petersen, Tania and Bonnet, Isabelle and Aubry, Alexandra and Bachir, Marwa and Gyde, Esther and Morel, Florence and Poignon, Corentin and Rached, Brigitte and Pourcher, Valérie and Rioux, Christophe and Vallois, Dorothée and Veziris, Nicolas and Robert, Jérôme and Guglielmetti, Lorenzo},
title = {Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment},
journal = {Emerging Infectious Diseases},
year = {2025},
volume = {31},
number = {3},
doi = {10.3201/eid3103.241473}
}
EUVIMED